RxDoctor Payments Data

Tamara Wright, MD

Family Medicine · Cutler Bay, FLNPI 1710056155

Payments from drug & device makers

$1,215in general payments, 2019–2025

Across 62 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$291
  • Viiv Healthcare Company$160
  • Sanofi Pasteur Inc.$98
  • AstraZeneca$82
  • Abbott$82
  • Dexcom, Inc.$66
  • plus $436 from 15 others

What the payments were for

  • Food & beverage$1,215100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,215 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$477
Medicare patients
23
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JulucaDolutegravir/Rilpivirine30$112,688
BiktarvyBictegrav/Emtricit/Tenofov Ala22$88,390
SymtuzaDarunavir/Cob/Emtri/Tenof Alaf14$79,610
TriumeqAbacavir/Dolutegravir/Lamivudi13$43,086
OdefseyEmtricitab/Rilpiviri/Tenof Ala12$40,870
OzempicSemaglutide13$15,401
JanuviaSitagliptin Phosphate17$11,730
EntrestoSacubitril/Valsartan14$9,329
FarxigaDapagliflozin Propanediol12$7,807
SymbicortBudesonide/Formoterol Fumarate25$5,656
Lopinavir-RitonavirLopinavir/Ritonavir12$4,952
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,915
Albuterol Sulfate HfaAlbuterol Sulfate43$855
Famotidine36$722
Ciclopirox13$627

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Viiv Healthcare CompanyJuluca, Triumeq$160$155,77443 claims
GileadBiktarvy$291$88,39022 claims
AstraZenecaFarxiga, Symbicort$82$13,46337 claims
MerckJanuvia$63$11,73017 claims
NovartisEntresto$24$9,32914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Cutler Bay

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →